ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Discussion
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gregory A. Thomas
Larry W. Stephenson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, G. A.
Right arrow Articles by Stephenson, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, G. A.
Right arrow Articles by Stephenson, L. W.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2000;70:1281-1289
© 2000 The Society of Thoracic Surgeons


Original articles: cardiovascular

Functional assessment of skeletal muscle ventricles after pumping for up to four years in circulation

Gregory A. Thomas, MDa,b, Robert L. Hammond, PhDa,b, Kevin Greer, MDa,b, Huiren Lu, MDa,b, Jonathan C. Jarvis, PhDa,b, Adam P. Shortland, PhDa,b, D. Mark Pullan, FRCSa,b, Stanley Salmons, PhDa,b, Larry W. Stephenson, MDa,b

a Division of Cardiothoracic Surgery, Department of Surgery, Wayne State University, Detroit, Michigan, USA
b Department of Human Anatomy and Cell Biology, University of Liverpool, Liverpool, United Kingdom

Address reprint requests to Dr Stephenson, Division of Cardiothoracic Surgery, Wayne State University, Suite 2102 Harper Professional Building, 3990 John R St, Detroit, MI 48201

Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Background. The successful treatment of cardiac failure by heart transplantation is severely limited by the shortage of donor organs, and alternative surgical approaches are needed. An experimental approach that holds considerable promise is the skeletal muscle ventricle (SMV), an auxiliary blood pump formed from a pedicled graft of latissimus dorsi muscle and connected to the circulation in a cardiac assist configuration. Adaptive transformation, or conditioning, by electrical stimulation enables the skeletal muscle to perform a significant proportion of cardiac work indefinitely without fatigue.

Methods. In 10 dogs, SMVs were constructed from the latissimus dorsi muscle, lined internally with pericardium, and conditioned by electrical stimulation to induce fatigue resistant properties. The SMVs were connected to the descending thoracic aorta via two 12-mm Gore-Tex conduits and the aorta was ligated between the two grafts. The SMV was stimulated to contract during the diastolic phase of alternate cardiac cycles. The animals were monitored at regular intervals.

Results. At initial hemodynamic assessment, SMV contraction augmented mean diastolic blood pressure by 24.6% (from 61 ± 7 to 76 ± 9 mm Hg). Presystolic pressure was reduced by 15% (from 60 ± 8 to 51 ± 7 mm Hg) after an assisted beat. Four animals died early, 1 from a presumed arrhythmia, and 3 during propranolol-induced hypotension. The other 6 animals survived for 273, 596, 672, 779, 969, 1,081, and 1,510 days. Diastolic augmentation was 27.4% at 1 year (93 ± 9 vs 73 ± 6 mm Hg; n = 5), 34.7% at 2 years (85 ± 6 vs 63 ± 7 mm Hg; n = 3), 21.2% (89 ± 10 vs 73 ± 8 mm Hg; n = 2) at 3 years, and 34.5% (78 vs 58 mm Hg; n = 1) after 4 years in circulation. After 4 years, the isolated SMV was able to maintain a pressure of over 80 mm Hg while ejecting fluid at 20 mL/s. No animal showed evidence of SMV rupture or thromboembolism.

Conclusions. The SMVs in this study provided effective and stable hemodynamic assistance over an extended period of time. There was no evidence that the working pattern imposed on the muscular wall of the SMV compromized its viability. Areas of fibrofatty degeneration were suggestive of early damage that future protocols should seek to minimize.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Despite advances in medical treatment, end-stage congestive heart failure remains a significant cause of morbidity and mortality, with over 100,000 patients dying each year in the United States alone [1]. Because of the lack of available donor hearts, cardiac transplantation can be performed on only about 2% to 3% of these potential candidates (UNOS Registry Data, 1996). Mechanical assist devices and total artificial hearts provide a bridge to transplantation but do nothing to increase the donor pool. Other surgical approaches, such as the use of left ventricular assist devices as permanent assist devices, cardiomyoplasty, and partial left ventricular reduction (Batista procedure), have attracted interest but have yet to show a consistent, long-term improvement in survival for patients with congestive heart failure [26].

Over the last 15 years, we have been seeking to establish a surgical approach to chronic cardiac assistance based on the use of muscular pumping chambers, which we call skeletal muscle ventricles (SMVs). These SMVs have been connected to the circulation in a variety of ways to provide both left and right ventricular assistance [710]. The configuration with which we have had the most long-term success is one in which the SMV is connected via a bifurcated graft to the descending thoracic aorta; the SMV then functions as an aortic diastolic counterpulsator, in a manner somewhat analogous to the intraaortic balloon pump. In 1994, we reported on 10 animals that had pericardium-lined SMVs placed in circulation with this configuration [11]. Here, we report hemodynamic data on this cohort of animals followed up to 4 years, together with a more detailed functional and histological assessment of the SMV that pumped chronically in circulation for 4 years.


    Material and methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Construction of SMVs
In 10 adult female beagles, weighing from 8 to 11 kg, pericardium-lined skeletal muscle ventricles were constructed from the left latissimus dorsi muscle. All animals were operated upon in accordance with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH publication 85-23, revised 1985). After induction of inhalation anesthesia, the latissimus dorsi muscle was dissected free from subcutaneous tissue and the chest wall, leaving its humeral insertion and the thoracodorsal nerve and blood vessels intact. A bipolar nerve cuff electrode (model 4080; Medtronic, Inc, Minneapolis, MN) was placed around the proximal portion of the nerve and secured in place.

The parietal pericardium was harvested between the two phrenic nerves via an eighth interspace thoracotomy. The visceral surface of this pericardium was applied to a polypropylene mandrel with the approximate shape of a truncated cone, having a base of 30 mm diameter, a height of 65 mm, and a volume of 25 mL (approximately 2.5 mL/kg body weight). The base of the mandrel was lined with a 5-mm ring of Dacron felt (USCI, Billerica, MA) and the pericardium was sewn to this ring with 6-0 polypropylene suture so that the entire surface of the mandrel was covered with pericardium. At this stage, a 16-mm ultrasonic flow probe (Transonic Systems, Inc, Ithaca, NY) was placed around the main pulmonary artery to record total cardiac output. The end of the flow probe was placed under the skin in the dorsal subcutaneous tissue.

The thoracolumbar fascia of the latissimus dorsi muscle graft was then attached to the Dacron sewing ring at the base of the mandrel so that the muscle was wrapped around the mandrel 2 to 2.5 times. Layers of the SMV were sewn to each other with absorbable suture, and the SMV was left in a subcutaneous position near the left axilla. The nerve lead was connected to a pulse generator (Itrel model 7421; Medtronic, Inc) that was placed beneath the left rectus abdominis muscle. Stimulation was switched on briefly to confirm that the system was functioning; the stimulator was then programmed to the "off" state and the incision closed in layers with absorbable suture.

Conditioning
The animals were allowed to recover for 3 weeks, the so-called vascular delay, to allow for some development of a collateral blood supply. After this, the stimulator was programmed to deliver continuous indirect stimulation to the SMV at a frequency of 2 Hz, with a duration of 210 µs and an amplitude of 1.0 to 2.0 V. This was continued for a 6-week period to induce transformation of the muscle to a uniform population of slow twitch, fatigue-resistant (type I) fibers, as described previously [12].

Connection to the circulation
After 9 weeks (3 weeks’ vascular delay plus 6 weeks’ conditioning), the animals were again anesthetized. The mandrel was removed from the SMV, and the inner pericardial lining inspected. The left chest was opened through a fifth interspace thoracotomy. Two 12-mm, ringed Gore-Tex conduits (W.L. Gore and Associates, Flagstaff, AZ) were anastomosed to the descending aorta in an end-to-side fashion. The two conduits were sutured to circular openings in a conically shaped base cap, which was connected to the base of the SMV via the Dacron felt ring. Figure 1 shows a schematic drawing of the SMV connected to the circulation.



View larger version (66K):
[in this window]
[in a new window]
 
Fig 1. Schematic diagram of the SMV in circulation. Connection to the descending thoracic aorta is made via a conical base cap with two conduits sewn to the base of the SMV. The aorta is ligated between the two conduits. The cardiomyostimulator senses the cardiac R-wave and then stimulates the muscle via the thoracodorsal nerve after a delay that places contraction within diastole.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Length of Time in Circulation and Cause of Death

 
Two myocardial sensing electrodes (sutureless-type 6917A-35T; Medtronic, Inc) were placed on the left ventricle. The nerve lead and myocardial leads were connected to an R-wave synchronous pulse train stimulator (SP6100 Prometheus, or SP1005 Cardiomyostimulator; Medtronic, Inc). The choice of stimulator depended upon availability; the Prometheus stimulator was preferred when it was available. Stimulation parameters for the two stimulators have been previously published [11]. Both were programmed to deliver a burst of impulses at 33 Hz during diastole on alternate cardiac cycles (1:2 assist ratio).

The thoracic aorta was ligated between the two conduits to direct blood flow through the SMV. With the SMVs contracting, the conduits were deaired and the clamps were removed, placing the SMV in circulation.

Hemodynamic data collection and analysis
Hemodynamic data were recorded initially at the time of connection to the circulation, again after 2 to 4 weeks in circulation, and subsequently at 2- to 3-month intervals. At the time of connection to the circulation, pressures in the femoral artery, the carotid artery, and the SMV were recorded with a fluid-filled column connected to a pressure transducer (Spectramed, Oxnard, CA). Pressures in the aortic arch and the left ventricle were measured with 5F microtransducer-tipped catheters (Millar Instruments, Inc, Houston, TX). Cardiac output was derived from the ultrasonic flow probe (Transonic Systems, Inc) that had been placed around the pulmonary artery. The data were collected with a Gould ES 1000B recording and display system (Gould Instruments, Inc, Cleveland, OH). Data were also sampled digitally with a real-time data acquisition system (AT-CODAS; Dataq Instruments, Inc, Akron, OH) at a 200-Hz sampling rate and stored on a computer. Stored data were analyzed offline with a data analysis software program (Windaq; Dataq Instruments, Inc).

Subsequent hemodynamic recordings were made with percutaneously placed, fluid-filled catheters in the femoral and carotid arteries, as long as these arteries remained patent. The flow probe was accessed subcutaneously to record cardiac output. In 9 of the animals, SMV function was assessed under hypotensive, low-cardiac output conditions induced by infusion of propranolol.

Hemodynamic data are expressed as mean ± standard deviation. Statistical significance was accepted at p value less than 0.05, determined by repeated-measures analysis of variance calculated with a statistical software package (INSTAT; Graphical Software, San Diego, CA).

Measurements on the isolated skeletal muscle ventricle
One dog was the subject of a more detailed terminal assessment, conducted electively after the SMV had been pumping in circulation for over 4 years. After the hemodynamic measurements in circulation, made as already described, the proximal and distal conduits connecting the SMV to the aorta were clamped. The femoral arterial pressure trace indicated that there was adequate distal perfusion, the result of a partial recanalization of the ligated section of aorta between the conduits. The SMV was detached by cutting the conduits, and its base was sewn to a silicone rubber connecting piece that was connected to a computer-controlled servo-pump. The neuromuscular stimulating electrodes were disconnected from the implantable cardiomyostimulator and connected to an external stimulator. The stimulator and the servo-pump were controlled by the same computer. Pressure monitored within the SMV cavity was fed back to the controller. The SMV and servo-pump were filled with a degassed saline solution, and care was taken to remove any air bubbles. The SMV was compressed manually and the corresponding position of the pump, representing zero volume of the SMV, was noted. The volume of the SMV could subsequently be determined from the position of the piston within the servo-pump. The characteristics of the SMV as an independent hydraulic pump were then determined by stimulating the muscle at a series of fixed volumes corresponding to a predetermined range of preload pressures and then at a series of flow rates imposed by the programmed movement of the piston within the servo-pump. The hydraulic performance of the SMV from the 4-year dog was compared with similar measurements taken from a SMV constructed acutely in a sheep after 6 weeks of conditioning its latissimus dorsi muscle.

Histology, histochemistry, and immunocytochemistry
At the end of the experiment, the SMV was removed from the animal that had survived for 4 years, and samples were taken for histological, histochemical, and immunocytochemical analysis. Samples were taken at three levels (proximal, middle, and distal, where proximal means nearest to the basal, or open end of the SMV) and at four cardinal points (designated north, south, east, west, looking at the basal end, where south was nearest the chest and north nearest the skin). In addition, samples were taken from the pedicle, that is to say, the unwrapped portion of the muscle used to construct the SMV. Nine biopsies were taken from the contralateral latissimus dorsi muscle. Three samples were taken across the muscle at each of three levels (proximal, middle, distal, where proximal was nearest to the narrow, humeral insertion). Each sample was mounted on a cork disc, which was marked to indicate the orientation and then placed in melting isopentane above liquid nitrogen. The frozen specimen was wrapped in cooled aluminum foil and maintained below -77°C, pending use.

Cryostat sections of 10-µm thickness were stained by the regressive hematoxylin and eosin method for general morphological assessment, by the hematoxylin-van Gieson method to demonstrate connective tissue structures, and histochemically for the demonstration of succinic dehydrogenase, and for myofibrillar ATPase with acid and alkali preincubation. Serial sections were reacted with monoclonal antibodies specific for the heavy chains of fast, slow and neonatal myosin, which were visualized by a peroxidase technique [13].

Sections were viewed by transmitted light in a Leitz Diaplan microscope equipped with a Vario Orthomat 2 camera system (Leica UK, Milton Keynes, UK) and photographed on Kodak Ektachrome 160T film for color transparencies or Ilford Pan F for black-and-white negatives.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Hemodynamics
In the following account, "control" refers to baseline values obtained during a prolonged period of unassisted beats. Contraction of the SMV during cardiac diastole resulted in a significant increase in mean diastolic blood pressure. For the standard protocol, in which stimulation was delivered in bursts of 33 Hz, the magnitude of this increase ranged from 21% to 39% of control, for all animals and throughout the measurement period. Pressure augmentation was measured at the proximal aorta immediately after connection and at the femoral artery for the chronic measurements. Stimulation at higher burst frequencies (50 and 85 Hz) appeared to produce greater diastolic augmentation than stimulation at 33 Hz, but the difference was statistically significant only for 85 Hz, and then only during the first 3 months of pumping in circulation.

Relaxation of the SMV produced a significant decrease in arterial pressure immediately preceding the next left ventricular ejection (presystolic pressure). The magnitude of the presystolic pressure drop ranged from 11% to 32% of control values for stimulation at 33 Hz. There was a modest reduction, of 1% to 11% of control values, in the peak systolic pressure generated by the left ventricle during the cycle after SMV relaxation.

In 1 dog, the SMV functioned effectively for over 4 years in circulation. In this animal, diastolic augmentation at 4 years was 34.5% at 33 Hz (39% at 50 Hz). In the cycle after SMV contraction, presystolic pressure was reduced by 32% at 33 Hz (48% at 50 Hz). Figure 2 shows pressure tracings obtained during hemodynamic measurements on this animal at various time points. The hemodynamic performance of this animal over time is compared with the rest of the group in Figure 3.



View larger version (83K):
[in this window]
[in a new window]
 
Fig 2. Pressure and electrocardiographic tracings recorded from the longest surviving animal at the time of connection (A), and after 1 year (B), 2 years (C), and 4 years (D) in the circulation. Stimulation burst frequency is 33 Hz at a 1:2 assist ratio. (Fem P = blood pressure measured at the femoral artery; Carotid P = pressure measured at the carotid artery.)

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig 3. Augmentation of mean diastolic pressure at 33-Hz burst frequency, expressed as a percentage of the unassisted mean diastolic pressure, over the period of study for the dog surviving for 4 years (open circles) and for the other dogs in the experimental group (closed circles). At connection, n = 10; at 6 months, n = 6; at 1 year, n = 5; at 2 years, n = 3; at 3 years, n = 2.

 
Figure 4 shows changes in mean diastolic blood pressure and minimum diastolic pressure (presystolic unloading) averaged for all animals over the duration of the study.



View larger version (36K):
[in this window]
[in a new window]
 
Fig 4. Changes in mean diastolic pressure (A) and presystolic pressure (B) as measured in the thoracic aorta or femoral artery. (Filled columns = Control values, from a prolonged period with the stimulator "off"; open columns = stimulation of the SMV at 33-Hz burst frequency; cross-hatched columns = stimulation of the SMV at either 50- or 85-Hz burst frequency.) Data are averaged for all dogs alive at each time point (at connection, n = 10; at 6 months, n = 6; at 1 year, n = 5; at 2 years, n = 3; at 3 years, n = 2; and at 4 years, n = 1.)

 
Performance of the isolated SMV
After the measurements described above had been completed, a more detailed functional assessment was made in the case of the SMV that had pumped in circulation for over 4 years. The conduits connecting the SMV to the aorta were clamped and divided, and the SMV was connected to a computer-controlled servo-pump to characterize its hydraulic performance under closely specified conditions. Figure 5a illustrates the pressure generated by the SMV during ejections of fluid at controlled flow rates from 0 to 60 mL/s. The curves can also be interpreted as the flow that could be generated by the SMV against a given pressure; for example, the SMV could pump at a flow rate of 20 mL/s against a pressure of 80 mm Hg. Figure 5b illustrates recordings made under identical conditions for an SMV that was constructed acutely in a sheep. Despite the difference in species and the time for which the SMV had pumped in circulation in the dog, Figures 5a and 5b reveal considerable similarities between the hydraulic pumping characteristics of these two ventricles.



View larger version (19K):
[in this window]
[in a new window]
 
Fig 5. (a) Pressure developed by the SMV of the dog surviving for 4 years, measured under controlled conditions after disconnecting it from the aorta. The traces represent pressures (in mm Hg) developed during ejection of saline solution under isovolumetric conditions (flow = 0), and for constant flow rates up to 60 mL/s. (b) Similar graph for a SMV constructed and tested acutely in a sheep. The hydraulic pumping performance of the SMVs is similar, despite the species difference and the 4-year difference in functional history.

 
Long-term survival
Table 1 summarizes the length of time for which each dog in this series was maintained with a SMV in circulation and the cause of death in each case. One animal died suddenly 1 day after the SMV was placed in circulation; post mortem examination did not establish the cause of death, which was therefore presumed to be an arrhythmia. Three dogs died within 2 weeks of connecting the SMVs to the circulation as a result of an inadvertent overdose of the propranolol infusion used to assess SMV function during low cardiac output [11]. Six other dogs survived the propranolol infusion, and in these animals, the SMVs pumped from 273 to 1,510 days in circulation. The stimulator in one of these animals reached end-of-life without any replacement stimulator being available; 2 other animals eventually developed infection at their flow probes. All 3 of these animals were euthanized "electively" because of these complications. Another animal died secondary to an inadvertent anesthetic complication during a measurement at 1,081 days. The remaining 2 were sacrificed electively to permit a complete hemodynamic and histological evaluation.

In each animal, the SMV was examined echocardiographically for signs of thrombus formation inside the SMV at the time that the hemodynamic measurements were performed. No evidence of thrombus was seen in any of the serial echocardiographs.

Post mortem examination
Each of the animals in this study underwent a complete autopsy at the time of its death. This included examination of the SMV, the heart and lungs, the abdominal organs, including the kidneys, and also the spinal cord. No animal showed evidence of distal embolization to any of the organs or spinal cord. The inner linings of the SMVs were smooth and showed no sign of thrombus formation. In the dogs that died early, a separate lining could be identified, although it was adherent to the SMV wall. In the longer term dogs, the pericardium could not be identified as a discrete structure.

Histological, histochemical, and immunocytochemical findings
The SMV that had pumped in circulation for over 4 years had, like the others, been placed in the subcutaneous tissue between the skin and the chest wall of the dog. One reason for taking samples of the SMV wall from four cardinal points at three levels was to ascertain whether this subcutaneous placement had resulted in pressure necrosis. The histological condition of the muscle wall varied greatly. The best preserved muscle was indistinguishable morphologically from control tissue, even in terms of fiber size and the thickness of interfascicular septa (Fig 6A). This was the appearance found at the locations identified as proximal west and south, middle north and east, and distal south and east (see Material and Methods for sampling scheme). In the least well-preserved samples, muscle tissue had been replaced largely or entirely by fibrous and fatty connective tissue; this was the nature of the wall at distal north and west. Other sites had an intermediate appearance (Fig 6B). There appeared to be no systematic trend in these observations; in particular, the deep and superficial sampling sites (south and north, respectively) appeared to be no less viable than the more lateral (west and east) sites. We assume that the damage observed was related primarily to the need to fold and to suture the muscle during surgical configuration as a ventricle, rendering some areas more vulnerable to ischemia. This would be consistent with the results of a previous study, in which we evaluated 44 SMVs after various times in circulation; we noted then that most of the fibrotic changes occurred in the first 3 weeks and that the muscle condition subsequently remained stable [14].



View larger version (139K):
[in this window]
[in a new window]
 
Fig 6. Photomicrographs of sections from the wall of the SMV of the dog surviving for 4 years, stained histologically by the regressive hematoxylin and eosin technique (A, B) and immunohistochemically with antibodies to myosin heavy chain isoforms (C–E). (A) Full-thickness section of the wall at middle east (see Material and Methods for sampling scheme); the luminal surface is seen on the right, and is partly detached. The pericardial layer can no longer be distinguished as a discrete feature of this lining but has become continuous with superficial connective tissue of the SMV wall. Note the excellent morphological preservation and normal thickness of perimysial septa (bar = 1 mm). (B) Nearly full-thickness section of the wall at proximal north; again, the luminal surface is on the right. Note thicker lining and relatively undamaged muscle fascicles interspersed with areas of fibrofatty replacement. Same magnification as A. (C–E). Serial sections from middle west, stained with myosin heavy chain antibodies specific to the fast (C), slow (D), and neonatal (E) isoforms and photographed at the same magnification. All fibers stain negatively for fast myosin heavy chains and positively for slow myosin heavy chains, evidence of a history of continuous stimulation. Lack of staining for the neonatal isoform (C) confirms the absence of regenerative phenomena (bar = 400 µm).

 
To establish whether the muscle that was of normal histological appearance had in some way escaped stimulation, serial sections were stained immunocytochemically for fiber type-specific antibodies. In these sections, all the fibers were reactive to anti-slow myosin heavy chain and none of them to anti-fast myosin heavy chain, evidence of a complete and sustained transformation that was consistent with a continuous history of stimulation (Figs 6C, D). It should be borne in mind that in the normal latissimus dorsi muscle of the dog, only 30% of fibers are reactive to anti-slow myosin heavy chain. Moreover, the damage that was present in other parts of the ventricle was clearly focal, for the pedicle was composed entirely of muscle tissue, with no evidence of damage at any stage, and differed from the corresponding area of the contralateral control muscle only in being uniformly of the slow muscle type. In some of the samples, there were fascicles containing small fibers and some apparently split fibers, and a few fibers with internal nuclei. The small fibers resembled regenerating fibers, but we could reject this possibility, because immunocytochemical staining of serial sections showed these fibers to be reactive for anti-slow, but not anti-fast or anti-neonatal myosin (Figs 6C–E). Such fibers may have undergone atrophy without necrosis, or they may have regenerated at some earlier stage; at all events they were stable at the time of termination.

Because of the heterogeneous condition of the muscular wall, it was not possible, without having systematically sampled the whole SMV, to estimate what fraction of the SMV wall consisted of healthy muscle tissue. The functional status of the wall is reflected more appropriately in the ability of the SMV to develop pressure in circulation (Figs 2, 3, 4A) and to eject fluid under standardized conditions (Fig 5).


    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
The work presented here represents a collaboration of some 20 years’ standing between these two laboratories on the use of skeletal muscle for cardiac assistance. Since 1985, this collaboration has focused largely on the concept of the SMV as an auxiliary pump [1517]. During this period, the surgical procedures for constructing SMVs and for evaluating them in circulation have undergone progressive refinement. Two problems, in particular, needed to be addressed: rupture of SMVs at the sewing ring-muscle interface, and thromboembolism originating in the SMV.

In the present study, the procedures for constructing the SMVs incorporated a number of modifications designed to reduce the risk of these two complications. It was felt that the use of pericardium to line the blood-contacting surface of the SMV would help to decrease the risk of thrombus development in the SMV, and it may also have contributed to protection against SMV rupture. Stress at the muscle/sewing ring interface was reduced by including a wide strip of thoracolumbar fascia in the SMV-sewing ring anastomosis and by using a conical base cap.

The success of these measures may be judged by the fact that of the 10 animals in the present series, none suffered SMV rupture or embolic complications. Two dogs were terminated electively. With one exception (a presumed arrhythmia), death in all the other animals was a direct or indirect consequence of hemodynamic monitoring or pharmacological intervention, procedures that were necessary to the experimental evaluation of the SMVs but were unrelated to the normal functioning of the SMV.

At the time of connecting the SMVs in circulation, we undertook and reported an extensive evaluation of the hemodynamic effects of SMV contraction on left ventricular function [11]. Performance parameters derived from those measurements included end-systolic elastance, preload recruitable stroke work, and endocardial viability ratio, and illustrated the ability of the SMV to share the workload, and to improve the efficiency, of the native left ventricle. We would have liked to record the same hemodynamic data throughout the study, but this proved impossible because cannulating repeatedly for retrograde placement of a left ventricular micromanometer resulted in carotid occlusions that denied us further access to the left ventricle. However, arterial pressure tracings recorded at 2- to 3-month intervals for up to 4 years were essentially stable (see Fig 2), so it is likely that the influence of SMV contraction on left ventricular mechanics was similarly maintained.

A unique feature of our terminal evaluation of the SMV that pumped for over 4 years was the data collected after isolating the ventricle from the circulation and connecting it to a servo-controlled hydraulic apparatus. By stimulating the SMV to pump under these closely controlled conditions, we could examine its ability to eject fluid against different pressures. It was encouraging to find that the data collected in this way agreed closely with data that we had obtained from similar SMVs constructed acutely in the sheep. This agreement is suggestive of underlying relationships that are, to some extent at least, independent of the animal model and time in circulation. By extension, they suggest that these animal experiments would be of some predictive value if extrapolated to clinical application in humans.

In this experiment, SMVs were used to assist the normal heart. To examine the potential for providing assistance during heart failure, 9 dogs in the study were assessed acutely for 1 hour under low-output conditions induced by propranolol infusion. The SMVs continued to provide diastolic augmentation and afterload reduction during this simulation of profound heart failure [11]. These results are not necessarily indicative of the performance to be expected in long-standing heart failure, but it is equally possible that SMVs would function even more effectively in more clinically relevant situations, where the level of heart failure tends to be less extreme and more gradual in onset.

Histological examination of the wall of the SMV that pumped in circulation for more than 4 years revealed a very heterogeneous appearance, with excellent preservation of muscle tissue in some areas and conversion to fibrofatty tissue in others. The results of a previous study [14] would suggest that the degenerative changes had occurred at an early stage after configuration and connection of the SMV in circulation. Certainly, there was no evidence of ongoing degenerative/regenerative changes at the time of examination. The fact that some of the muscle was of completely normal appearance, even after functioning for this length of time, confirms that the working conditions were sustainable. Earlier observations [18] showed that stimulation causes damage only when combined with other factors, such as ischemia and reduced resting tension, that compromise the ability of the muscle to meet the metabolic challenge. Recent work [1921] indicates that a moderate regime of electrical stimulation delivered before surgical mobilization could significantly enhance blood flow to the distal part of the latissimus dorsi muscle graft, and may therefore be a route to achieving improved viability of the muscle when it is mobilized and configured as a ventricle.

Parallel work, completed since the present study was initiated, suggests that changes in the patterns for stimulation and activation of the SMV could contribute further to the success of the procedure. Conditioning of the muscles in these experiments followed an established protocol that induces a full fast-to-slow fiber type transformation. Recently, we have shown that a stable fast-fatigue resistant state, similar to that of naturally occurring type 2A fibers, can be induced and maintained by stimulation patterns that deliver fewer impulses to the muscle [13, 22, 23]. Such a state would confer the advantages of better preservation of mass, force-generating capacity, contractile speed, and power [24], and some authors are already advocating this approach in the context of cardiomyoplasty [25].

In terms of the chronic application of the SMV approach, we have had the most experience, and best long-term success, with SMVs connected in an aorto-aortic configuration, as in the present study, with stimulation timed to provide diastolic counterpulsation. This is not, however, the only possible configuration, and we have also investigated an approach in which the SMV is connected between the left ventricular apex and the aorta [9, 26]. Our results suggest that the reduction in left ventricular stroke work available in this configuration is greater than for the aorto-aortic connection, although there is a higher risk of thromboembolism originating within either the SMV or the valved conduits. Other configurations currently under investigation elsewhere have a SMV placed directly in series [27] or in parallel with the aorta [28].

Useful diastolic augmentation may also be obtained by wrapping the latissimus muscle around the aorta. This procedure, known as aortomyoplasty, has been performed clinically in about 30 cases [29]. Aortomyoplasty has the advantage that it does not expose blood to a new interface. However, cardiac assist is constrained by the existing geometry of the aorta to a small stroke volume. In the descending aorta, this can be enlarged only by sacrificing arterial branches to the spinal cord, with the associated risk of paraplegia. In addition, the small diameter of the descending aorta results in a wall tension that fails to load the skeletal muscle wrap adequately. The muscle cannot then operate under the conditions required for optimum power. From a hydraulic point of view, the ascending aorta has a better geometry, but the presence of great vessels requires splitting the latissimus dorsi flap, and the short available length can be compensated only by creating an artificial aneurysm. The SMV, on the other hand, is not limited by existing structures, and its geometry can be optimized to produce maximum pumping power, resulting in significant flow as well as pressure augmentation.

In summary, we have shown that SMVs can provide effective cardiac assistance for periods up to and exceeding 4 years. Improvements in the procedure have resulted in a low incidence of complications related directly to the SMV. After pumping blood continuously in circulation for over 4 years in the longest surviving animal, SMV contraction was still augmenting diastolic pressure by 34.5%, and reducing peak systolic pressure by 10% and presystolic pressure by 32%. Areas of fibrofatty degeneration were found in the muscular wall of this SMV, but the stability of its hemodynamic performance over time suggests that such damage occurred early, probably as an immediate consequence of mobilizing and configuring the muscle as a ventricle. This view is supported by the fact that there was no immunocytochemical evidence of ongoing degenerative/regenerative events. It follows that skeletal muscle pumps can sustain this working level for very prolonged periods. Further refinement of the protocol for mobilizing, conditioning, and configuring the grafted muscle should result in a more uniformly viable muscular wall and improvements in pumping performance. There is every indication from this study that the eventual transfer of this technique to provide long-term cardiac assistance in a clinical setting is an achievable target. Currently, we are focusing experimental efforts towards documenting SMV performance for this and other circulatory configurations in models of chronic left ventricular failure as a necessary step before clinical application.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
This work was supported by grant HL-34778 from the National Institutes of Health (Larry W. Stephenson, MD), and by Programme Grant RG/97001 from the British Heart Foundation (Stanley Salmons, PhD, Jonathan C. Jarvis, PhD). We thank Jill Currie for her expert technical assistance with the histological studies.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
This article has been selected for the open discussion forum on the STS Web site: http://www.sts.org/section/atsdiscussion/


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Smith W.M. Epidemiology of congestive heart failure. Am J Cardiol 1985;55:3-8A.[Medline]
  2. Furnary A.P., Chachques J.C., Moreira L.F.P., et al. Long-term outcome, survival analysis, and risk stratification of dynamic cardiomyoplasty. J Thorac Cardiovasc Surg 1996;112:1640-1649.[Abstract/Free Full Text]
  3. Suma H., Isomura T., Horii T., et al. Two-year experience of the Batista operation for non-ischemic cardiomyopathy. J Cardiol 1998;32:269-276.[Medline]
  4. Chacques J.C., Marino J.P., Lajos P., et al. Dynamic cardiomyoplasty. Eur J Cardiothorac Surg 1997;12:560-568.[Abstract]
  5. McCarthy J.F., McCarthy P.M., Starling R.C., et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg 1998;13:337-343.[Abstract/Free Full Text]
  6. McCarthy P.M., Smedira N.O., Vargo R.L., et al. One hundred patients with the HeartMate left ventricular assist device. J Thorac Cardiovasc Surg 1998;115:904-912.[Abstract/Free Full Text]
  7. Anderson D.R., Pochettino A., Hammond R.L., et al. Autogenously lined skeletal muscle ventricles in circulation. Up to nine months’ experience. J Thorac Cardiovasc Surg 1991;101:661-670.[Abstract]
  8. Niinami H., Hooper T.L., Hammond R.L., et al. Skeletal muscle ventricles in the pulmonary circulation. Ann Thorac Surg 1992;53:750-757.[Abstract]
  9. Lu H., Fietsam R., Jr , Hammond RL, et al. Skeletal muscle ventricles: left ventricular apex to aorta configuration. Ann Thorac Surg 1993;55:78-85.[Abstract]
  10. Hooper T.L., Niinami H., Lu H., et al. Skeletal muscle ventricles as left atrial-aortic pumps. Ann Thorac Surg 1992;54:316-322.[Abstract]
  11. Thomas G.A., Lu H., Isoda S., et al. Pericardium-lined skeletal muscle ventricles in circulation up to 589 days. Ann Thorac Surg 1994;58:978-988.[Abstract]
  12. Mannion J.D., Bitto T., Hammond R.L., Rubinstein N.A., Stephenson L.W. Histochemical and fatigue characteristics of conditioned canine latissimus dorsi muscle. Circ Res 1986;58:298-304.[Abstract/Free Full Text]
  13. Mayne C.N., Sutherland H., Jarvis J.C., et al. Induction of a fast-oxidative phenotype by chronic muscle stimulation. Am J Physiol 1996;270:C313-C320.[Abstract/Free Full Text]
  14. Nakajima H., Nakajima H.O., Thomas G.A., et al. Chronic morphologic changes of skeletal-muscle ventricles in circulation. Ann Thorac Surg 1994;57:912-920.[Abstract]
  15. Acker M.A., Hammond R., Mannion J.D., Salmons S., Stephenson L.W. An autologous biologic pump motor. J Thorac Cardiovasc Surg 1986;12:733-746.
  16. Mannion J.D., Hammond R., Stephenson L.W. Hydraulic pouches of canine latissimus dorsi. Potential for left ventricular assistance. J Thorac Cardiovasc Surg 1986;91:534-544.[Abstract]
  17. Acker M.A., Hammond R.L., Mannion J.D., Salmons S., Stephenson L.W. Skeletal muscle as the potential power source for a cardiovascular pump. Science 1987;236:324-327.[Abstract/Free Full Text]
  18. El Oakley R.M., Jarvis J.C., Barman D., et al. Factors affecting the integrity of latissimus dorsi muscle grafts. J Heart Lung Transpl 1995;14:359-365.[Medline]
  19. Salmons S., Tang A.T.M., Jarvis J.C., et al. Morphological and functional evidence, and clinical importance, of vascular anastomoses in the latissimus dorsi muscle of the sheep. J Anat 1998;193:93-104.
  20. Tang A.T.M., Jarvis J.C., Hooper T.L., Salmons S. Observation and basis of improved blood flow to the distal latissimus dorsi muscle. Cardiovasc Res 1998;40:131-137.[Abstract/Free Full Text]
  21. Tang A.T.M., Jarvis J.C., Hooper T.L., Salmons S. Cardiomyoplasty. Ann Thorac Surg 1999;68:46-51.[Abstract/Free Full Text]
  22. Jarvis J.C., Sutherland H., Mayne C.N., Gilroy S.J., Salmons S. Induction of a fast-oxidative phenotype by chronic muscle stimulation. Am J Physiol 1996;270:C306-C312.[Abstract/Free Full Text]
  23. Sutherland H., Jarvis J.C., Kwende M.M.N., Gilroy S.J., Salmons S. The dose-related response of rabbit fast muscle to long-term low-frequency stimulation. Muscle & Nerve 1998;21:1632-1646.[Medline]
  24. Salmons S., Jarvis J.C. The working capacity of skeletal muscle transformed for use in a cardiac assist role. In: Chiu R.C.-J., Bourgeois I.M., eds. . Transformed muscle for cardiac assist and repair. Mount Kisco, NY: Futura Publishing Company Inc, 1990:89-104.
  25. Carraro U., Docali G., Barbiero M., et al. Demand dynamic cardiomyoplasty. Basic Appl Myol 1998;8:11-15.
  26. Thomas G.A., Baciewicz F.A., Jr, Hammond R.L., et al. Power output of pericardium-lined skeletal muscle ventricles, left ventricular apex to aorta configuration. J Thorac Cardiovasc Surg 1998;116:1029-1042.[Abstract/Free Full Text]
  27. Guldner N.W., Eichstaedt H.C., Klapproth P., et al. Dynamic training of skeletal muscle ventricles. A method to increase muscular power for cardiac assistance. Circulation 1994;89:1032-1040.[Abstract/Free Full Text]
  28. Girsch W., Koller R., Lanmuller H., et al. Experimental development of an electrically stimulated biological skeletal muscle ventricle for chronic aortic counterpulsation. Eur J Cardiothorac Surg 1998;13:78-83.[Abstract/Free Full Text]
  29. Trianini J.C. Dynamic cardiomyoplasty and aortomyoplasty. Basic Appl Myol 1999;8:413-418.

Related Article

Discussion
Ann. Thorac. Surg. 2000 70: 1290. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
N. W Guldner, P. Klapproth, P. R. Margaritoff, R. Noel, H. H Sievers, and M. Grossherr
Impact of Valves in a Biomechanical Heart Model Assisting Failing Hearts
Asian Cardiovasc Thorac Ann, December 1, 2009; 17(6): 592 - 597.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Salmons
Cardiac assistance from skeletal muscle: a reappraisal
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 204 - 213.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. R. Ramnarine, M. Capoccia, Z. Ashley, H. Sutherland, M. Russold, N. Summerfield, S. Salmons, and J. C. Jarvis
Counterpulsation From the Skeletal Muscle Ventricle and the Intraaortic Balloon Pump in the Normal and Failing Circulations
Circulation, July 4, 2006; 114(1_suppl): I-10 - I-15.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Salmons
Cardiac Assistance From Skeletal Muscle: Should We Be Downhearted?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1101 - 1103.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Monnet and J. C. Chachques
Animal Models of Heart Failure: What Is New?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
L. W. Stephenson
History of Cardiac Surgery
Card. Surg. Adult, January 1, 2003; 2(2003): 3 - 29.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
B. G. Patel, S. H. Shah, L. I. Astra, R. L. Hammond, Z. A. Sharif, P. J. McDonald, and L. W. Stephenson
Skeletal muscle ventricle aortic counterpulsation: function during chronic heart failure
Ann. Thorac. Surg., February 1, 2002; 73(2): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. W. Guldner, P. Klapproth, M. Gro{beta}herr, A. Brugge, A. Sheikhzadeh, R. Tolg, E. Rumpel, R. Noel, and H.-H. Sievers
Biomechanical Hearts: Muscular Blood Pumps, Performed in a 1-Step Operation, and Trained Under Support of Clenbuterol
Circulation, August 7, 2001; 104(6): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Lopez-Guajardo, H. Sutherland, J. C. Jarvis, and S. Salmons
Induction of a fatigue-resistant phenotype in rabbit fast muscle by small daily amounts of stimulation
J Appl Physiol, May 1, 2001; 90(5): 1909 - 1918.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. A. Thomas and L. W. Stephenson
Update 2001: Skeletal muscle ventricles: left ventricular apex to aorta configuration
Ann. Thorac. Surg., May 1, 2001; 71(5): 1736 - 1737.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Discussion
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gregory A. Thomas
Larry W. Stephenson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, G. A.
Right arrow Articles by Stephenson, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, G. A.
Right arrow Articles by Stephenson, L. W.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS